Steven R. Cox

975 total citations
35 papers, 714 citations indexed

About

Steven R. Cox is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Steven R. Cox has authored 35 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 9 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Steven R. Cox's work include Drug Transport and Resistance Mechanisms (8 papers), Inflammatory mediators and NSAID effects (7 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Steven R. Cox is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Inflammatory mediators and NSAID effects (7 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Steven R. Cox collaborates with scholars based in United States, United Kingdom and Italy. Steven R. Cox's co-authors include Joseph F. Boucher, Alessandra Marti, Peter Koehler, Michael Stegemann, Garrett J. Vangiessen, Jeffrey W. Cox, Mary J. Ruwart, R.G Clemence, H. A. Benchaoui and Richard Schneider and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmacology and Experimental Therapeutics and The Journal of Pediatrics.

In The Last Decade

Steven R. Cox

35 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven R. Cox United States 15 196 154 134 85 83 35 714
A. Van Peer Belgium 18 209 1.1× 212 1.4× 145 1.1× 128 1.5× 113 1.4× 37 1.4k
T. Taylor United States 23 196 1.0× 102 0.7× 76 0.6× 242 2.8× 142 1.7× 75 1.1k
Beatrice M. Magnusson Australia 15 96 0.5× 148 1.0× 189 1.4× 62 0.7× 66 0.8× 23 1.2k
Kelly Pittman United States 22 678 3.5× 138 0.9× 168 1.3× 82 1.0× 59 0.7× 57 1.4k
Tomasz Grabowski Poland 13 190 1.0× 84 0.5× 134 1.0× 44 0.5× 74 0.9× 114 788
F A deLuna United States 15 130 0.7× 166 1.1× 292 2.2× 60 0.7× 42 0.5× 24 844
H Laufen Germany 22 325 1.7× 176 1.1× 186 1.4× 40 0.5× 67 0.8× 76 1.5k
Nasir Idkaidek Jordan 17 174 0.9× 123 0.8× 111 0.8× 20 0.2× 59 0.7× 70 840
J. K. Faulkner United Kingdom 16 137 0.7× 109 0.7× 68 0.5× 44 0.5× 56 0.7× 32 1.1k
B. Diquet France 18 210 1.1× 159 1.0× 76 0.6× 22 0.3× 48 0.6× 62 1.2k

Countries citing papers authored by Steven R. Cox

Since Specialization
Citations

This map shows the geographic impact of Steven R. Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven R. Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven R. Cox more than expected).

Fields of papers citing papers by Steven R. Cox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven R. Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven R. Cox. The network helps show where Steven R. Cox may publish in the future.

Co-authorship network of co-authors of Steven R. Cox

This figure shows the co-authorship network connecting the top 25 collaborators of Steven R. Cox. A scholar is included among the top collaborators of Steven R. Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven R. Cox. Steven R. Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Collard, Wendy T., Steven R. Cox, Gurprit Grover, et al.. (2011). Pharmacokinetics of ceftiofur crystalline‐free acid sterile suspension in the equine. Journal of Veterinary Pharmacology and Therapeutics. 34(5). 476–481. 33 indexed citations
3.
Cox, Steven R., C. McLaughlin, Mark Yancey, et al.. (2010). Rapid and prolonged distribution of tulathromycin into lung homogenate and pulmonary epithelial lining fluid of Holstein calves following a single subcutaneous administration of 2.5 mg/kg body weight.. 8(3). 129–137. 30 indexed citations
4.
Cox, Steven R., et al.. (2010). The pharmacokinetics of mavacoxib, a long‐acting COX‐2 inhibitor, in young adult laboratory dogs. Journal of Veterinary Pharmacology and Therapeutics. 33(5). 461–470. 66 indexed citations
5.
Lai, Yurong, Kathleen E. Sampson, Larissa M. Balogh, et al.. (2010). Preclinical and Clinical Evidence for the Collaborative Transport and Renal Secretion of an Oxazolidinone Antibiotic by Organic Anion Transporter 3 (OAT3/SLC22A8) and Multidrug and Toxin Extrusion Protein 1 (MATE1/SLC47A1). Journal of Pharmacology and Experimental Therapeutics. 334(3). 936–944. 22 indexed citations
6.
Hickman, M. Anne, et al.. (2008). Safety, pharmacokinetics and use of the novel NK‐1 receptor antagonist maropitant (CereniaTM) for the prevention of emesis and motion sickness in cats. Journal of Veterinary Pharmacology and Therapeutics. 31(3). 220–229. 65 indexed citations
7.
Benchaoui, H. A., Steven R. Cox, Richard Schneider, Joseph F. Boucher, & R.G Clemence. (2007). The pharmacokinetics of maropitant, a novel neurokinin type‐1 receptor antagonist, in dogs. Journal of Veterinary Pharmacology and Therapeutics. 30(4). 336–344. 54 indexed citations
8.
Sarapa, Nenad, Steven R. Cox, Steven F. Francom, et al.. (2003). Valdecoxib, a COX‐2‐Specific Inhibitor, Does Not Affect Cardiac Repolarization. The Journal of Clinical Pharmacology. 43(9). 974–982. 2 indexed citations
9.
Shelton, Mark, et al.. (2003). Pharmacokinetics of Ritonavir and Delavirdine in Human Immunodeficiency Virus-Infected Patients. Antimicrobial Agents and Chemotherapy. 47(5). 1694–1699. 12 indexed citations
10.
Grasela, Thaddeus H., et al.. (1999). An Automated Drug Concentration Screening and Quality Assurance Program for Clinical Trials. Drug Information Journal. 33(1). 273–279. 6 indexed citations
11.
Cheng, Ching‐Ling, David E. Smith, Peggy L. Carver, et al.. (1997). Steady-state pharmacokinetics of delavirdine in HIV-positive patients: Effect on erythromycin breath test *. Clinical Pharmacology & Therapeutics. 61(5). 531–543. 54 indexed citations
12.
Paliwal, Jyoti, et al.. (1993). Stereoselective, competitive, and nonlinear plasma protein binding of ibuprofen enantiomers as determinedin vivo in healthy subjects. Journal of Pharmacokinetics and Biopharmaceutics. 21(2). 145–161. 35 indexed citations
13.
Jamali, Fakhreddin, et al.. (1991). Stereoselective disposition of ibuprofen enantiomers in the isolated perfused rat kidney.. Pharmaceutical Research. 8(12). 1520–1524. 14 indexed citations
14.
Schmith, Virginia D., Steven R. Cox, Michael A. Zemaitis, & Patricia D. Kroboth. (1991). New high-performance liquid chromatographic method for the determination of alprazolam and its metabolites in serum: instability of 4-hydroxyalprazolam. Journal of Chromatography B Biomedical Sciences and Applications. 568(1). 253–260. 17 indexed citations
15.
Cox, Steven R., et al.. (1991). Pharmacokinetics of the R(−) and S(+) Enantiomers of Ibuprofen in the Serum and Synovial Fluid of Arthritis Patients. The Journal of Clinical Pharmacology. 31(1). 88–94. 12 indexed citations
16.
Small, Ralph E., Steven R. Cox, & Wade J. Adams. (1990). Influence of H2 Receptor Antagonists on the Disposition of Flurbiprofen Enantiomers. The Journal of Clinical Pharmacology. 30(7). 660–664. 12 indexed citations
17.
Cox, Steven R., et al.. (1988). Comparative human study of ibuprofen enantiomer plasma concentrations produced by two commercially available ibuprofen tablets. Biopharmaceutics & Drug Disposition. 9(6). 539–549. 21 indexed citations
18.
Cox, Steven R., et al.. (1985). Determination of ciglitazone in dog plasma by reversed-phase high-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 3(5). 483–487. 1 indexed citations
19.
Cox, Steven R., et al.. (1985). Liquid Chromatographic Assay for Fluoxymesterone in Human Serum with Application to a Preliminary Bioavailability Study. Journal of Pharmaceutical Sciences. 74(3). 308–311. 1 indexed citations
20.
Cox, Steven R.. (1980). High performance liquid chromatographic analysis of mitoxantrone in biological samples and preliminary pharmacokinetic studies in dogs and human cancer patients /. OhioLink ETD Center (Ohio Library and Information Network). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Van Peer Breakdown of academic impact, for papers by T. Taylor Breakdown of academic impact, for papers by Beatrice M. Magnusson Breakdown of academic impact, for papers by Kelly Pittman Breakdown of academic impact, for papers by Tomasz Grabowski Breakdown of academic impact, for papers by F A deLuna Breakdown of academic impact, for papers by H Laufen Breakdown of academic impact, for papers by Nasir Idkaidek Breakdown of academic impact, for papers by J. K. Faulkner Breakdown of academic impact, for papers by B. Diquet
Rankless by CCL
2026